Abstract | BACKGROUND:
Bacteremia is one of the leading causes of mortality in living-donor liver transplant (LDLT) recipients. Lymphocytes, including natural killer cells, are believed to play a role in the first line of defense against invading infectious microbes. METHODS: From January 2004 to December 2009, 114 consecutive LDLT recipients were studied for postoperative bacteremia. The impact of adjuvant immunotherapy using activated liver allograft-derived lymphocytes on bacteremia was retrospectively evaluated by a one-to-one match using propensity score to overcome bias due to the different distribution of covariates for the two groups. RESULTS: After one-to-one matching, 21 patients who did not receive adjuvant immunotherapy and 21 who did not receive adjuvant immunotherapy had the same preoperative and operative characteristics. Six (28.6%) of the 21 patients who did not receive adjuvant immunotherapy had bacteremia, whereas only one (4.8%) of the 21 patients who received adjuvant immunotherapy had bacteremia; thus, the incidence of bacteremia in patients who had received adjuvant immunotherapy was significantly lower than that in patients who had not received adjuvant immunotherapy (P=0.038). CONCLUSIONS: Adjuvant immunotherapy using liver allograft-derived lymphocytes may be a promising modality for reducing the postoperative bacteremia after LDLT.
|
Authors | Hirotaka Tashiro, Kohei Ishiyama, Masahiro Ohira, Yuka Igarashi, Hiroyuki Tahara, Kentaro Ide, Takashi Onoe, Yuka Tanaka, Hideki Ohdan |
Journal | Transplantation
(Transplantation)
Vol. 92
Issue 5
Pg. 575-80
(Sep 15 2011)
ISSN: 1534-6080 [Electronic] United States |
PMID | 21822169
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Topics |
- Adolescent
- Adult
- Aged
- Bacteremia
(etiology, prevention & control)
- Female
- Humans
- Immunotherapy
(methods)
- Killer Cells, Natural
(immunology, transplantation)
- Liver
(cytology, immunology)
- Liver Transplantation
(adverse effects, immunology)
- Living Donors
- Lymphocyte Activation
- Lymphocyte Transfusion
- Male
- Matched-Pair Analysis
- Middle Aged
- Natural Killer T-Cells
(immunology, transplantation)
- Retrospective Studies
- Transplantation, Homologous
- Young Adult
|